Last reviewed · How we verify
Suppression of Recurrent Herpes Simplex Infection
Approved treatments
- Famvir · Novartis
Famvir works by inhibiting the replication of herpes simplex virus DNA through its action as a nucleoside analog DNA polymerase inhibitor. - Aciclovir · Assistance Publique Hopitaux De Marseille
- Zovirax · Ligand Pharms
Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating. - Valtrex · GSK
Valtrex works by inhibiting the replication of herpes simplex virus DNA through interference with viral DNA polymerase. - ACYC · Ligand Pharms
Acyc works by binding to a specific target in the body, although its exact mechanism is unknown.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Suppression of Recurrent Herpes Simplex Infection patent landscape — cliff calendar, originator estates, attackable patents
- Suppression of Recurrent Herpes Simplex Infection treatment landscape brief
- Suppression of Recurrent Herpes Simplex Infection treatment updates RSS
Frequently asked questions about Suppression of Recurrent Herpes Simplex Infection
What drugs treat Suppression of Recurrent Herpes Simplex Infection?
Tracked treatments include Famvir, Aciclovir, Zovirax, Valtrex, ACYC.
What is the treatment for Suppression of Recurrent Herpes Simplex Infection?
Standard treatment for Suppression of Recurrent Herpes Simplex Infection includes Famvir, Aciclovir, Zovirax, Valtrex, ACYC. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Suppression of Recurrent Herpes Simplex Infection patent cliff · Suppression of Recurrent Herpes Simplex Infection CI report
- Treatment: Famvir · Novartis
- Treatment: Aciclovir · Assistance Publique Hopitaux De Marseille
- Treatment: Zovirax · Ligand Pharms
- Treatment: Valtrex · GSK
- Treatment: ACYC · Ligand Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing